A significant breakthrough in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in several types of cancer, leading https://bookmarkproduct.com/story22066167/mini-antibodies-restore-the-p53-protein-the-new-pathway-for-tumor-treatment